| Bioactivity | N3-PEG8-Phe-Lys-PABC-Gefitinib is a drug-linker conjugate for ADC with potent antitumor activity by using the anti-tumor agent, Gefitinib (orally active EGFR tyrosine kinase inhibitor), linked via the cleavable linker N3-PEG8-Phe-Lys-PABC. |
| Name | N3-PEG8-Phe-Lys-PABC-Gefitinib |
| Formula | C60H81ClFN11O15 |
| Molar Mass | 1250.80 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
N3-PEG8-Phe-Lys-PABC-Gefitinib
CAS: F: C60H81ClFN11O15 W: 1250.80
N3-PEG8-Phe-Lys-PABC-Gefitinib is a drug-linker conjugate for ADC with potent antitumor activity by using the anti-tumor
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.